chlorthalidone has been researched along with prednisone in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Nieth, H | 1 |
| MASSI, GB | 1 |
| DEGEN, CE | 1 |
| COMOLI, G; GHIRINGHELLI, L; MADULI, S | 1 |
| CEREDA, UG; FRANZINI, P | 1 |
1 review(s) available for chlorthalidone and prednisone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
10 other study(ies) available for chlorthalidone and prednisone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
[Therapy of the nephrotic syndrome].
Topics: Adrenocorticotropic Hormone; Azathioprine; Chlorambucil; Chlorthalidone; Diet, Sodium-Restricted; Dietary Proteins; Diuretics; Furosemide; Glucocorticoids; Humans; Hydrochlorothiazide; Immunosuppressive Agents; Mercaptopurine; Methandrostenolone; Nephrotic Syndrome; Prednisolone; Prednisone | 1968 |
[The new diuretics].
Topics: Acetazolamide; Chlorothiazide; Chlorthalidone; Diuretics; Prednisolone; Prednisone; Spironolactone | 1962 |
[ON THE TREATMENT OF SUDECK'S SYNDROME WITH DELTABUTAZOLIDIN].
Topics: Atrophy; Blood Sedimentation; Chlorthalidone; Humans; Phenylbutazone; Physical Therapy Modalities; Prednisone; Reflex Sympathetic Dystrophy | 1963 |
[DIURETIC THERAPY OF DECOMPENSATED HEPATIC CIRRHOSIS].
Topics: Blood Chemical Analysis; Chlorothiazide; Chlorthalidone; Diuresis; Diuretics; Electrolytes; Humans; Hydrochlorothiazide; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Prednisone; Progesterone; Spironolactone; Urine | 1963 |
[ON THE SUBJECT OF DIURESIS WITH METOPIRONE (SU-4885)].
Topics: Acetazolamide; Ascites; Chlorthalidone; Diuresis; Diuretics; Humans; Ketones; Liver Cirrhosis; Metyrapone; Mineralocorticoid Receptor Antagonists; Organomercury Compounds; Prednisone; Spironolactone | 1964 |